ERtugliflozin triAl in DIabetes With Preserved or Reduced ejeCtion FrAcTion mEchanistic Evaluation in Heart Failure

NCT03416270 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Heart Failure

Interventions

DRUG: Ertugliflozin
DRUG: Placebo

Sponsor

University Health Network, Toronto

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]